MX2020002809A - Genes rep de aav inducibles. - Google Patents

Genes rep de aav inducibles.

Info

Publication number
MX2020002809A
MX2020002809A MX2020002809A MX2020002809A MX2020002809A MX 2020002809 A MX2020002809 A MX 2020002809A MX 2020002809 A MX2020002809 A MX 2020002809A MX 2020002809 A MX2020002809 A MX 2020002809A MX 2020002809 A MX2020002809 A MX 2020002809A
Authority
MX
Mexico
Prior art keywords
aav
aav rep
rep genes
rep68
rep78
Prior art date
Application number
MX2020002809A
Other languages
English (en)
Inventor
Silke Wissing
Nicole Faust
Kerstin Hein
Original Assignee
Cevec Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cevec Pharmaceuticals Gmbh filed Critical Cevec Pharmaceuticals Gmbh
Publication of MX2020002809A publication Critical patent/MX2020002809A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material
    • C12N2750/14152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14161—Methods of inactivation or attenuation

Abstract

La presente invención se refiere a células huésped que comprenden un ácido nucleico que codifica las proteínas Rep78 y Rep68 del virus adenoasociado (AAV), en donde el promotor interno de AAV p19 ha sido inactivado por una o más mutaciones que mantienen la funcionalidad de dichas proteínas Rep78 y Rep68. La presente invención se refiere además a ácidos nucleicos respectivos y vectores que comprenden los mismos, así como a métodos respectivos para la producción de AAV.
MX2020002809A 2017-09-19 2018-09-18 Genes rep de aav inducibles. MX2020002809A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17001562.2A EP3456822A1 (en) 2017-09-19 2017-09-19 Inducible aav rep genes
PCT/EP2018/075158 WO2019057691A1 (en) 2017-09-19 2018-09-18 INDAVTIBLE AAV GEN GENES

Publications (1)

Publication Number Publication Date
MX2020002809A true MX2020002809A (es) 2020-10-12

Family

ID=59930156

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020002809A MX2020002809A (es) 2017-09-19 2018-09-18 Genes rep de aav inducibles.

Country Status (13)

Country Link
US (2) US11685932B2 (es)
EP (2) EP3456822A1 (es)
JP (1) JP7254777B2 (es)
KR (1) KR20200052283A (es)
CN (1) CN111108197A (es)
AU (1) AU2018337571A1 (es)
BR (1) BR112020005404A2 (es)
CA (1) CA3073622A1 (es)
IL (1) IL273176A (es)
MX (1) MX2020002809A (es)
SG (1) SG11202000443SA (es)
WO (1) WO2019057691A1 (es)
ZA (1) ZA202000862B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230257770A1 (en) * 2020-02-04 2023-08-17 Oxford Genetics Limited Process for Making Adenoassociated Viral Vectors
WO2023086822A2 (en) * 2021-11-09 2023-05-19 Asimov Inc. Stable production systems for aav vector production
WO2023171698A1 (ja) * 2022-03-08 2023-09-14 富士フイルム株式会社 プロデューサー細胞、プロデューサー細胞の製造方法、およびアデノ随伴ウイルスの製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE264398T1 (de) 1995-12-01 2004-04-15 Crucell Holland Bv Regulierte expression von proteinen in stabil transformierten säugetierzellen
DE19905501B4 (de) 1999-02-10 2005-05-19 MediGene AG, Gesellschaft für molekularbiologische Kardiologie und Onkologie Verfahren zur Herstellung eines rekombinanten Adeno-assoziierten Virus, geeignete Mittel hierzu sowie Verwendung zur Herstellung eines Arzneimittels
AU2002367943A1 (en) * 2001-12-18 2003-12-22 University Of North Carolina At Chapel Hill Improved reagents and methods for producing parvoviruses
US9441206B2 (en) * 2011-10-28 2016-09-13 The University Of North Carolina At Chapel Hill Cell line for production of adeno-associated virus

Also Published As

Publication number Publication date
AU2018337571A1 (en) 2020-01-30
US11685932B2 (en) 2023-06-27
EP3456822A1 (en) 2019-03-20
JP7254777B2 (ja) 2023-04-10
RU2020111459A3 (es) 2021-11-29
CN111108197A (zh) 2020-05-05
CA3073622A1 (en) 2019-03-28
JP2020536505A (ja) 2020-12-17
KR20200052283A (ko) 2020-05-14
IL273176A (en) 2020-04-30
US20230348936A1 (en) 2023-11-02
RU2020111459A (ru) 2021-10-20
ZA202000862B (en) 2021-02-24
BR112020005404A2 (pt) 2020-09-29
EP3649239A1 (en) 2020-05-13
US20200277628A1 (en) 2020-09-03
WO2019057691A1 (en) 2019-03-28
SG11202000443SA (en) 2020-02-27

Similar Documents

Publication Publication Date Title
MX2016010649A (es) Vector de virus adeno-asociado.
MX2018012376A (es) Sistemas de replicón de arterivirus recombinantes y usos de estos.
PH12019500068A1 (en) Novel adeno-associated virus capsid proteins
MX2019004499A (es) Sistemas de replicón de virus recombinante y usos de estos.
MX2022006652A (es) Proteinas de capside modificadas para un suministro mejorado de vectores de parvovirus.
MX2018014152A (es) Composiciones y métodos para tratar la enfermedad de huntington.
MX2018013139A (es) Composiciones detergentes y sus usos.
MX2017014125A (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.
EA201792236A1 (ru) Получение увеличенных в размере векторов на основе аденоассоциированного вируса
MX2020005282A (es) Vector para la produccion de particulas aav.
EP3741849A3 (en) Protease variants and polynucleotides encoding same
CA3062698A1 (en) Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
MX2017006216A (es) Composiciones y métodos para tratar la esclerosis lateral amiotrófica (ela).
MX2020002809A (es) Genes rep de aav inducibles.
WO2016081927A3 (en) Genome-modified recombinant adeno-associated virus vectors
WO2016066756A3 (en) Protease variants and polynucleotides encoding same
WO2016066757A3 (en) Protease variants and polynucleotides encoding same
MX2019000140A (es) Variantes de xilanasa y polinucleotidos que las codifican.
CL2016000502A1 (es) Vectores mejorados del factor viii del virus adeno-asociado de menos de 5,0 kb de longitud, que producen un polipéptido del factor viii funcionalmente activo para el tratamiento de la hemofilia a.
MX2023001119A (es) Variantes de enzimas y polinucleotidos que las codifican.
MX2017007731A (es) Composiciones de detergente, variantes de lipasa y polinucleotidos que codifican las mismas.
EA202090540A1 (ru) Ген, придающий устойчивость к патогенному грибу
MX2018008051A (es) Variantes de beta-glucanasa y polinucleotidos que las codifican.
EA201792080A1 (ru) Гуманизированные анти-c1s антитела и способы их применения
EA202091712A1 (ru) МОДИФИЦИРОВАННЫЙ КАПСИДНЫЙ БЕЛОК rAAV ДЛЯ ГЕННОЙ ТЕРАПИИ